Priming of cytotoxic T lymphocytes by DNA vaccines: Requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes

被引:231
|
作者
Fu, TM [1 ]
Ulmer, JB [1 ]
Caulfield, MJ [1 ]
Deck, RR [1 ]
Friedman, A [1 ]
Wang, S [1 ]
Liu, X [1 ]
Donnelly, JJ [1 ]
Liu, MA [1 ]
机构
[1] MERCK RES LABS, DEPT VIRUS & CELL BIOL, W POINT, PA 19486 USA
关键词
D O I
10.1007/BF03401683
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: MHC class I molecule-restricted cytotoxic T-lymphocyte (CTL) responses are induced following either intramuscular (i.m.) injection of a DNA plasmid encoding influenza virus nucleoprotein (NP) or transplantation of myoblasts stably transfected with the NP gene, the latter indicating that synthesis of NP by myocytes in vivo is sufficient to induce CTL. The present study was designed to investigate the role of muscle cells and involvement of professional antigen-presenting cells (APCs) in priming CTL responses following DNA vaccination. Materials and Methods: Parent --> F1 bone marrow (BM) chimeric mice were generated whose somatic cells include muscle cells bearing both parental MHC haplo-types, while their professional APCs express only the donor MHC haplotypes. Results and Conclusions: Upon injection of NP DNA, or after infection with influenza virus, CTL responses generated in the chimeras were restricted to the donor MHC haplotype. Thus cells of BM lineage were definitively shown to be responsible for priming such CTL responses after infection or DNA immunization. Moreover, expression of antigen by muscle cells in BM chimeric mice after myoblast transplantation is sufficient to induce CTL restricted only by the MHC haplotype of the donor BM. This indicates that transfer of antigen from myocytes to professional APCs can occur, thus obviating a requirement for direct transfection of BM-derived cells.
引用
收藏
页码:362 / 371
页数:10
相关论文
共 50 条
  • [1] Priming of Cytotoxic T Lymphocytes by DNA Vaccines: Requirement for Professional Antigen Presenting Cells and Evidence for Antigen Transfer from Myocytes
    Tong-Ming Fu
    Jeffrey B. Ulmer
    Michael J. Caulfield
    R. Randall Deck
    Arthur Friedman
    Su Wang
    Xu Liu
    John J. Donnelly
    Margaret A. Liu
    H. Wigzell
    Molecular Medicine, 1997, 3 : 362 - 371
  • [2] Role of antigen-presenting cells in cross-priming of cytotoxic T lymphocytes by apoptotic cells
    Ronchetti, A
    Iezzi, G
    Crosti, MC
    Garancini, MP
    Protti, MP
    Bellone, M
    JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (02) : 247 - 251
  • [3] PRIMING ANTIVIRAL CYTOTOXIC T-LYMPHOCYTES - REQUIREMENT FOR CD4(+) CELLS IS DEPENDENT ON THE ANTIGEN-PRESENTING CELL IN-VIVO
    CIAVARRA, RP
    TEDESCHI, B
    CELLULAR IMMUNOLOGY, 1994, 157 (01) : 132 - 143
  • [4] CD8+T Cell Priming by Dendritic Cell Vaccines Requires Antigen Transfer to Endogenous Antigen Presenting Cells
    Yewdall, Alice W.
    Drutman, Scott B.
    Jinwala, Felecia
    Bahjat, Keith S.
    Bhardwaj, Nina
    PLOS ONE, 2010, 5 (06):
  • [6] Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells
    Jean-Baptiste Latouche
    Michel Sadelain
    Nature Biotechnology, 2000, 18 : 405 - 409
  • [7] Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells
    Latouche, JB
    Sadelain, M
    NATURE BIOTECHNOLOGY, 2000, 18 (04) : 405 - 409
  • [8] PRIMING OF CYTOTOXIC T-CELLS BY ANTIGEN FEEDING
    KAGNOFF, MF
    GASTROENTEROLOGY, 1977, 72 (05) : 1076 - 1076
  • [9] Artificial antigen-presenting cells are superior to dendritic cells at inducing antigen-specific cytotoxic T lymphocytes
    Shao, Jie
    Xu, Qiuping
    Su, Shu
    Wei, Jia
    Meng, Fanyan
    Chen, Fangjun
    Zhao, Yang
    Du, Juan
    Zou, Zhengyun
    Qian, Xiaoping
    Liu, Baorui
    CELLULAR IMMUNOLOGY, 2018, 334 : 78 - 86
  • [10] IN-VITRO PRIMING OF CYTOTOXIC T-LYMPHOCYTES AGAINST POORLY IMMUNOGENIC EPITOPES BY ENGINEERED ANTIGEN-PRESENTING CELLS
    BELLONE, M
    IEZZI, G
    MANFREDI, AA
    PROTTI, MP
    DELLABONA, P
    CASORATI, G
    RUGARLI, C
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (11) : 2691 - 2698